Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study

BackgroundRecent research has shown promising results for the therapeutic benefits of psychedelics. One popular view claims that these benefits are mediated by the subjective experiences induced by these substances. Based on this, we designed a virtual reality experience, Psyrreal, that mimics the p...

Full description

Bibliographic Details
Main Authors: Karl Kristjan Kaup, Madis Vasser, Kadi Tulver, Mari Munk, Juhan Pikamäe, Jaan Aru
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1088896/full
_version_ 1827951050198351872
author Karl Kristjan Kaup
Madis Vasser
Kadi Tulver
Mari Munk
Juhan Pikamäe
Juhan Pikamäe
Jaan Aru
author_facet Karl Kristjan Kaup
Madis Vasser
Kadi Tulver
Mari Munk
Juhan Pikamäe
Juhan Pikamäe
Jaan Aru
author_sort Karl Kristjan Kaup
collection DOAJ
description BackgroundRecent research has shown promising results for the therapeutic benefits of psychedelics. One popular view claims that these benefits are mediated by the subjective experiences induced by these substances. Based on this, we designed a virtual reality experience, Psyrreal, that mimics the phenomenological components of psychedelic experiences.AimsWe aimed to investigate the therapeutic efficacy of Psyrreal and psychedelic VR experiences in treating depressive symptoms as well as explore the effect of Psyrreal on subjective factors which have been suggested to mediate the therapeutic benefits of psychedelics.MethodsIn this open-label feasibility study, thirteen participants with mild-to-moderate depression underwent a 2-day therapeutic intervention implementing Psyrreal. Depressive symptoms were evaluated by the Emotional State Questionnaire (EST-Q2) at the start of the intervention and 2 weeks after. A thematic analysis of semi-structured interviews after Psyrreal was also conducted as an additional assessment of the method.ResultsA 2-day intervention implementing Psyrreal led to significant decreases in depressive symptoms at the 2-week follow-up (n = 10, p = 0.007, Hedges’ g = 1.046) measured by the Emotional State Questionnaire (EST-Q2). The analysis of semi-structured interviews suggests that Psyrreal could lead to insight and alterations in the sense of self in some people.ConclusionThis work proposes a novel method using virtual reality to augment the treatment of psychological disorders as well as to precisely investigate the mediating subjective factors of the therapeutic effects of psychedelic substances. Our preliminary results suggest that VR experiences combined with psychological support show potential in treating depressive symptoms and further research into similar methods is warranted.
first_indexed 2024-04-09T13:35:37Z
format Article
id doaj.art-ee1a1b78c0a8403cbcbb3c22462e6b5c
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-04-09T13:35:37Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-ee1a1b78c0a8403cbcbb3c22462e6b5c2023-05-09T11:04:42ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-03-011410.3389/fpsyt.2023.10888961088896Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility studyKarl Kristjan Kaup0Madis Vasser1Kadi Tulver2Mari Munk3Juhan Pikamäe4Juhan Pikamäe5Jaan Aru6Institute of Computer Science, University of Tartu, Tartu, EstoniaInstitute of Computer Science, University of Tartu, Tartu, EstoniaInstitute of Computer Science, University of Tartu, Tartu, EstoniaPsychiatry Clinic of North Estonia Medical Centre, Tallinn, EstoniaInstitute of Computer Science, University of Tartu, Tartu, EstoniaInstitute of Molecular and Cell Biology, University of Tartu, Tartu, EstoniaInstitute of Computer Science, University of Tartu, Tartu, EstoniaBackgroundRecent research has shown promising results for the therapeutic benefits of psychedelics. One popular view claims that these benefits are mediated by the subjective experiences induced by these substances. Based on this, we designed a virtual reality experience, Psyrreal, that mimics the phenomenological components of psychedelic experiences.AimsWe aimed to investigate the therapeutic efficacy of Psyrreal and psychedelic VR experiences in treating depressive symptoms as well as explore the effect of Psyrreal on subjective factors which have been suggested to mediate the therapeutic benefits of psychedelics.MethodsIn this open-label feasibility study, thirteen participants with mild-to-moderate depression underwent a 2-day therapeutic intervention implementing Psyrreal. Depressive symptoms were evaluated by the Emotional State Questionnaire (EST-Q2) at the start of the intervention and 2 weeks after. A thematic analysis of semi-structured interviews after Psyrreal was also conducted as an additional assessment of the method.ResultsA 2-day intervention implementing Psyrreal led to significant decreases in depressive symptoms at the 2-week follow-up (n = 10, p = 0.007, Hedges’ g = 1.046) measured by the Emotional State Questionnaire (EST-Q2). The analysis of semi-structured interviews suggests that Psyrreal could lead to insight and alterations in the sense of self in some people.ConclusionThis work proposes a novel method using virtual reality to augment the treatment of psychological disorders as well as to precisely investigate the mediating subjective factors of the therapeutic effects of psychedelic substances. Our preliminary results suggest that VR experiences combined with psychological support show potential in treating depressive symptoms and further research into similar methods is warranted.https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1088896/fullpsychedelicsvirtual realitytherapytherapeutic mechanisms of psychedelicsaltered states of consciousness (ASC)VR-augmented therapy
spellingShingle Karl Kristjan Kaup
Madis Vasser
Kadi Tulver
Mari Munk
Juhan Pikamäe
Juhan Pikamäe
Jaan Aru
Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
Frontiers in Psychiatry
psychedelics
virtual reality
therapy
therapeutic mechanisms of psychedelics
altered states of consciousness (ASC)
VR-augmented therapy
title Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
title_full Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
title_fullStr Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
title_full_unstemmed Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
title_short Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
title_sort psychedelic replications in virtual reality and their potential as a therapeutic instrument an open label feasibility study
topic psychedelics
virtual reality
therapy
therapeutic mechanisms of psychedelics
altered states of consciousness (ASC)
VR-augmented therapy
url https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1088896/full
work_keys_str_mv AT karlkristjankaup psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy
AT madisvasser psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy
AT kaditulver psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy
AT marimunk psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy
AT juhanpikamae psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy
AT juhanpikamae psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy
AT jaanaru psychedelicreplicationsinvirtualrealityandtheirpotentialasatherapeuticinstrumentanopenlabelfeasibilitystudy